Literature DB >> 412484

[Fabry's disease. Carbamazepine therapy in acrodyniform syndrome].

G Lenoir, M Rivron, M C Gubler, J L Dufier, F S Tome, M Guivarch.   

Abstract

A 19 year old male affected with Fabry's disease suffered from severe nervous manifestations. Despite very peculiar pains of the extremities, the diagnosis has been missed for a long time and was painted out at this age because of sharp reconstitution of the family history. Fabry's disease was confirmed by discovering typical corneal lesion, a low leucocyte (W.B.C.) alpha-galactosidase activity and foam cells in renal glomerular epithelium. The importance of an early diagnosis is obvious in this case: 10 Instead of degrading narcotic therapy, Carbamazepin brought forward normal social and school living. 20 Familial investigations show up that all the siblings were affected (three boys including the propositus)--several symptoms were found in the heterozygous conductor mother. Despite the rarety of Fabry's disease, the authors emphasize the easiness of diagnosis on simple clinical and biochemical grounds. The authors insist on the symptomatic and therapeutic action of Carbamazepin or Diphenytoin in order to prevent painfull symptoms which often appear during initial course of the disease.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 412484

Source DB:  PubMed          Journal:  Arch Fr Pediatr        ISSN: 0003-9764


  5 in total

Review 1.  Anderson-Fabry disease.

Authors:  S H Morgan; M A Crawfurd
Journal:  BMJ       Date:  1988-10-08

2.  Fabry disease - current treatment and new drug development.

Authors:  Omid Motabar; Ellen Sidransky; Ehud Goldin; Wei Zheng
Journal:  Curr Chem Genomics       Date:  2010-07-23

3.  The early clinical phenotype of Fabry disease: a study on 35 European children and adolescents.

Authors:  Markus Ries; Uma Ramaswami; Rossella Parini; Bengt Lindblad; Catharina Whybra; Ingrid Willers; Andreas Gal; Michael Beck
Journal:  Eur J Pediatr       Date:  2003-09-20       Impact factor: 3.183

Review 4.  Fabry disease.

Authors:  Dominique P Germain
Journal:  Orphanet J Rare Dis       Date:  2010-11-22       Impact factor: 4.123

Review 5.  Pain management strategies for neuropathic pain in Fabry disease--a systematic review.

Authors:  Y Schuller; G E Linthorst; C E M Hollak; I N Van Schaik; M Biegstraaten
Journal:  BMC Neurol       Date:  2016-02-24       Impact factor: 2.474

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.